# ClinicalTrials.gov record NCT06934642

> PeptideScanner retained ClinicalTrials.gov record NCT06934642 at 2026-08-10T18:10:03.939Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06934642-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-15
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06934642-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06934642-tirzepatide-v1.json
- Content SHA-256: `39c682d348844baccbaec3444bffccab59f0b19979a7e8e661a6774832dfa5ec`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06934642 ([`ctg-observation-nct06934642-2026-07-15-ea694ee9a887`](#source-ctg-observation-nct06934642-2026-07-15-ea694ee9a887))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06934642 at 2026-08-10T18:10:03.939Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06934642-2026-07-15-ea694ee9a887`](#source-ctg-observation-nct06934642-2026-07-15-ea694ee9a887))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06934642 at 2026-08-10T18:10:03.939Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06934642-2026-07-15-ea694ee9a887`](#source-ctg-observation-nct06934642-2026-07-15-ea694ee9a887))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06934642-2026-07-15-ea694ee9a887`](#source-ctg-observation-nct06934642-2026-07-15-ea694ee9a887))

## Sources

<a id="source-ctg-observation-nct06934642-2026-07-15-ea694ee9a887"></a>
- **ClinicalTrials.gov record NCT06934642 · retained source version 2026-07-15:ea694ee9a887e110a5b2ebe5969e8429cfa7f3020cb898c99c2c89efbd20a3a7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06934642) (`ctg-observation-nct06934642-2026-07-15-ea694ee9a887`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06934642." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06934642-tirzepatide-v1.json SHA-256: 39c682d348844baccbaec3444bffccab59f0b19979a7e8e661a6774832dfa5ec.